Citation Impact
Citing Papers
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Conflict of Interest in Medical Research, Education, and Practice
2009 Standout
Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
2006
The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
2018
The Role of Maintenance Strategies in Metastatic Colorectal Cancer
2019
Cancer treatment and survivorship statistics, 2022
2022 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers
2004
The FGF family: biology, pathophysiology and therapy
2009 Standout
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Neutrophils at work
2014 Standout
Advances in stem cell mobilization
2012
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?
2017
Lifestyle-related factors and environmental agents causing cancer: An overview
2007 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
2004
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
2010 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients
2012
Adjuvant Therapy of Stage II and III Colon Cancer
2005
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK)
2005 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Updated clinical practice guidelines for the prevention and treatment of mucositis
2007
Alcohol and liver cancer
2005
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Idarubicin
1991
Staging of Colorectal Cancer: Past, Present, and Future
2005
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Interventions for preventing oral mucositis for patients with cancer receiving treatment
2011
In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer
2009
Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment Effect of Bevacizumab in Metastatic Colorectal Cancer
2005
Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394
2003
Multicenter Phase II Study of Nordic Fluorouracil and Folinic Acid Bolus Schedule Combined With Oxaliplatin As First-Line Treatment of Metastatic Colorectal Cancer
2003
Interventions for treating oral mucositis for patients with cancer receiving treatment
2010
Cancer treatment and survivorship statistics, 2019
2019 Standout
Cancer-linked targets modulated by curcumin.
2012
Thymidylate Synthase Expression and Prognosis in Colorectal Cancer: A Systematic Review and Meta-Analysis
2004
Anthraquinones As Pharmacological Tools and Drugs
2016 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of D. Turci being referenced
Prophylaxis with GM-CSF mouthwashes does not reduce frequency and duration of severe oral mucositis in patients with solid tumors undergoing high-dose chemotherapy with autologous peripheral blood stem cell transplantation rescue: a double blind, randomized, placebo-controlled study
2003
Thymidylate synthase protein expression in colorectalcancer metastases predicts for clinical outcome to leucovorin-modulated bolus or infusional 5-fluorouracil but not methotrexate-modulated bolus 5-fluorouracil
2002
A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization
2006
Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial
2010
Role of biological markers in the clinical outcome of colon cancer
2002
A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
2000
P3.02c-096 Use of Nivolumab in Elderly Patients with Advanced Squamous NSCLC: Results from the Italian Expanded Access Programme (EAP)
2017
Bolus Fluorouracil and Leucovorin With Oxaliplatin as First-Line Treatment in Metastatic Colorectal Cancer
2002
Mitoxantrone (M) and Vinblastine (V) in the Treatment of Advanced Breast Cancer
1990
Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities.
2001